What is the cardiovascular disease risk for a 55-year-old man with clinic blood pressure 140/90 mmHg, home blood pressure ≤130/85 mmHg, normal laboratory results including normal renal function and glycated hemoglobin 4.4%, but no lipid profile available?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cardiovascular Disease Risk Assessment

Direct Answer

This patient has LOW cardiovascular disease risk based on the clinical presentation of white-coat hypertension (elevated clinic BP 140/90 mmHg but home BP ≤130/85 mmHg), absence of diabetes (HbA1c 4.4%), normal kidney function, and no established cardiovascular disease in a 55-year-old male. 1

Blood Pressure Classification and White-Coat Hypertension

The discrepancy between clinic and home blood pressure readings indicates white-coat hypertension, which carries cardiovascular risk similar to normal blood pressure rather than true hypertension. 1

  • Clinic BP of 140/90 mmHg would classify as Grade 1 hypertension if sustained, but home readings ≤130/85 mmHg place this patient in the "elevated BP" or "high normal" category (130-139/85-89 mmHg). 2
  • Home BP readings ≤130/85 mmHg are associated with approximately 2-fold increased relative risk from CVD compared with optimal BP (<120/80 mmHg), but this is substantially lower than true Grade 1 hypertension. 2
  • The European Society of Cardiology recommends out-of-office BP measurement (home or ambulatory monitoring) when screening office BP is elevated to confirm true hypertension versus white-coat effect. 1

Risk Factor Analysis

This patient lacks the major risk factors and conditions that would elevate him to intermediate or high cardiovascular risk categories:

  • Age 55 years: While male sex and age >55 years are risk factors, they alone do not determine high risk without additional factors. 2
  • No diabetes: HbA1c of 4.4% is well below the 5.7% threshold for prediabetes, excluding this major risk factor. 2, 1
  • Normal kidney function: Absence of chronic kidney disease removes a major risk amplifier. 2, 1
  • No established CVD: No history of myocardial infarction, stroke, heart failure, or other clinical cardiovascular disease. 2
  • No target organ damage: Normal kidney function and no mention of left ventricular hypertrophy, proteinuria, or other end-organ damage. 2

Incomplete Risk Assessment

The absence of a lipid profile prevents complete formal cardiovascular risk calculation using SCORE or other validated risk assessment tools. 2, 1

  • Total cholesterol, LDL-C, and HDL-C are essential components of SCORE2 and other risk calculators. 2
  • HDL-C particularly modifies risk at all levels and can reclassify patients near risk thresholds. 2
  • Without lipid values, we cannot calculate a precise 10-year CVD risk percentage, but the clinical profile strongly suggests low risk. 1

Risk Stratification Framework

Based on European Society of Cardiology guidelines, this patient does NOT meet criteria for high or very high cardiovascular risk:

  • High risk requires: established CVD, diabetes mellitus, moderate-to-severe CKD (eGFR <60 mL/min/1.73m²), familial hypercholesterolemia, or hypertension-mediated organ damage—all absent here. 2, 1
  • Very high risk requires: documented atherosclerotic CVD, diabetes with target organ damage, severe CKD (eGFR <30), or calculated 10-year CVD risk ≥10%—all absent or unlikely. 2
  • The patient's profile (elevated office BP only, normal home BP, no diabetes, normal kidney function, age 55) suggests low-to-moderate risk at most. 2, 1

Clinical Management Implications

Lifestyle modifications are the primary intervention for this patient, with pharmacological treatment deferred until complete risk assessment with lipid profile is obtained:

  • The European Society of Cardiology recommends lifestyle modifications only (not pharmacological treatment) for patients with low CVD risk and white-coat hypertension. 1
  • BP should be monitored yearly with home measurements to ensure it remains controlled. 1
  • A complete lipid profile should be obtained to calculate formal 10-year CVD risk using SCORE2 (for European populations) or pooled cohort equations (for US populations). 1
  • If SCORE2 risk is <5% after obtaining lipids, the patient remains low risk and continues lifestyle measures only. 1

Important Caveats

Several factors could modify this assessment if additional information were available:

  • Smoking status: Current smoking would significantly increase risk and could shift the patient to intermediate risk. 2
  • Family history: Premature CVD in first-degree relatives (men <55 years, women <65 years) would increase risk. 2
  • Lipid profile: Severe dyslipidemia (total cholesterol >5.0 mmol/L or LDL-C >3.0 mmol/L) could elevate risk substantially. 2
  • Abdominal obesity: Waist circumference ≥102 cm would add metabolic risk. 2
  • Subclinical organ damage: Echocardiographic LVH, carotid plaque, or microalbuminuria would reclassify to higher risk. 2

Answer to Multiple Choice Question

A. Low Risk is the most appropriate answer given the available information. The patient has white-coat hypertension (not true sustained hypertension), no diabetes, normal kidney function, and no established cardiovascular disease. While the absence of a lipid profile prevents complete formal risk calculation, the clinical profile strongly indicates low cardiovascular risk rather than intermediate or high risk. 1

References

1
Guideline

Cardiovascular Disease Risk Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the approach to determining the cardiovascular disease (CVD) risk score for adult patients with risk factors like hypertension, diabetes, or high cholesterol?
What are examples of modifiable Cardiovascular Disease (CVD) risk factors that increase risk by less than 5%?
How to manage a patient with a cardiovascular disease (CVD) infarct and a Glasgow Coma Scale (GCS) score of 10?
What is the management plan for a patient with cardiovascular disease (CVD)?
What is the best approach to managing small vessel cardiovascular disease (CVD) in a 70-year-old patient with likely comorbidities and impaired renal function?
What is the process for obtaining prescription‑required ostomy supplies for a patient, including insurance authorization for private, Medicare, or Medicaid coverage?
For an adult with an iliac artery aneurysm and no connective‑tissue disease or severe hypertension, how often should imaging be performed to monitor its size based on the aneurysm diameter?
How can a primary‑care clinician obtain and prescribe ostomy supplies (e.g., pouch, skin barrier, wafer) for a patient with a colostomy or ileostomy?
Is bioidentical hormone therapy (BHRT) appropriate for menopausal symptom relief in a woman with a personal or strong family history of breast cancer, and what dosing, route, and monitoring are recommended to minimize cancer risk?
In an adult with vitamin B12 deficiency and neurological symptoms or impaired renal function, should I use methylcobalamin or cyanocobalamin, and what oral and intramuscular dosing regimens are recommended?
How should I assess and manage diarrhea in an elderly man, including indications for supportive care, further work‑up, and specific therapies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question